Researchers Discover Potential Link Between Keto Diet Metabolite and Enhanced CAR T Cell Cancer Treatment

A recent study suggests that a metabolite produced by the body during a ketogenic diet may have the potential to enhance the effectiveness of CAR T cell therapy, a type of immunotherapy used to treat certain types of cancer. The research, conducted by a team of scientists at a leading medical institution, found that the metabolite, called beta-hydroxybutyrate (BHB), can increase the energy and persistence of CAR T cells, allowing them to more effectively target and destroy cancer cells.